[
  {
    "ts": null,
    "headline": "1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction",
    "summary": "Stock market sell-offs are often great opportunities to buy dividend stocks.  One of the easiest ways to capitalize on this opportunity is to buy the Schwab U.S. Dividend Equity ETF (NYSEMKT: SCHD).  The Schwab U.S. Dividend Equity ETF strives to track the performance of the Dow Jones U.S. Dividend 100 Index, which aims to measure the returns of stocks with consistent records of paying higher-yielding dividends backed by stronger financial metrics than their peers.",
    "url": "https://finnhub.io/api/news?id=7ee4f06fadf96ab14515ca3d67b55500b0960df14973af8c1e07db6ef6a180d6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742163540,
      "headline": "1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction",
      "id": 133324574,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Stock market sell-offs are often great opportunities to buy dividend stocks.  One of the easiest ways to capitalize on this opportunity is to buy the Schwab U.S. Dividend Equity ETF (NYSEMKT: SCHD).  The Schwab U.S. Dividend Equity ETF strives to track the performance of the Dow Jones U.S. Dividend 100 Index, which aims to measure the returns of stocks with consistent records of paying higher-yielding dividends backed by stronger financial metrics than their peers.",
      "url": "https://finnhub.io/api/news?id=7ee4f06fadf96ab14515ca3d67b55500b0960df14973af8c1e07db6ef6a180d6"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie (NYSE:ABBV) Reports ELAHERE Success in Phase 3 Trials for Platinum-Resistant Ovarian Cancer",
    "summary": "AbbVie (NYSE:ABBV) has recently seen promising developments with the release of favorable final results from the MIRASOL trial of ELAHERE, demonstrating significant improvements for women with platinum-resistant ovarian cancer. Over the last quarter, the company's share price rose by 23%, bolstered by this promising news and other product-related announcements, including ELAHERE's prior full FDA approval and regulatory progress in other regions. This positive momentum contrasts with AbbVie’s...",
    "url": "https://finnhub.io/api/news?id=a9d41b6607b78a451aed2739ff8d4674f276898d66c2051e6eb7e117ec626298",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742145409,
      "headline": "AbbVie (NYSE:ABBV) Reports ELAHERE Success in Phase 3 Trials for Platinum-Resistant Ovarian Cancer",
      "id": 133184478,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (NYSE:ABBV) has recently seen promising developments with the release of favorable final results from the MIRASOL trial of ELAHERE, demonstrating significant improvements for women with platinum-resistant ovarian cancer. Over the last quarter, the company's share price rose by 23%, bolstered by this promising news and other product-related announcements, including ELAHERE's prior full FDA approval and regulatory progress in other regions. This positive momentum contrasts with AbbVie’s...",
      "url": "https://finnhub.io/api/news?id=a9d41b6607b78a451aed2739ff8d4674f276898d66c2051e6eb7e117ec626298"
    }
  },
  {
    "ts": null,
    "headline": "Kenvue + Johnson & Johnson: I Choose To Own The Whole 'Humpty Dumpty'",
    "summary": "Discover why Johnson & Johnson and Kenvue offer resilient defensive stocks with high dividends.",
    "url": "https://finnhub.io/api/news?id=0e2a33e42c67c50b9950b3dc91a0d5278a086f640ec0823eadf61648f4b4a945",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742132403,
      "headline": "Kenvue + Johnson & Johnson: I Choose To Own The Whole 'Humpty Dumpty'",
      "id": 133183958,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1494495584/image_1494495584.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Discover why Johnson & Johnson and Kenvue offer resilient defensive stocks with high dividends.",
      "url": "https://finnhub.io/api/news?id=0e2a33e42c67c50b9950b3dc91a0d5278a086f640ec0823eadf61648f4b4a945"
    }
  }
]